Switzerland
6 Vaccines Approved for Use in Switzerland
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: bag.admin.ch
RNA
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Protein Subunit
Novavax
Nuvaxovid
Approved in 40 countries
22 trials in 14 countries
Approval Source: seekingalpha.com
RNA
Moderna
Spikevax Bivalent Original/Omicron BA.1
Approved in 38 countries
5 trials in 4 countries
Approval Source: bloomberg.com
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: reuters.com
3 in Clinical Trials in Switzerland
RNA
Moderna
Spikevax
Approved in 88 countries
70 trials in 24 countries
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Protein Subunit
Emergex Vaccines Holding Ltd